Tanya Johnson, NP
Nurse Practitioner · Baltimore, MDNPI 1306513031
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,213 of the $5,536 with a category attached, or 76.1%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $55.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$1K
- Novo Nordisk$587
- AstraZeneca$585
- GSK$444
- Johnson & Johnson$342
- Lilly USA, LLC$254
- plus $2K from 24 others
What the payments were for
- Consulting fees$1,32324%
- Food & beverage$4,21376%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 2 | $1,323 |
| Novo Nordisk | 9 | $587 |
| AstraZeneca | 20 | $585 |
| GSK | 7 | $444 |
| Johnson & Johnson | 5 | $342 |
| Lilly USA, LLC | 9 | $254 |
| Exact Sciences | 7 | $171 |
| Hologic Sales And Service, LLC | 1 | $148 |
| Dexcom, Inc. | 2 | $142 |
| Napo Pharmaceuticals Inc | 1 | $133 |
| Insulet Corporation | 1 | $125 |
| Amgen | 1 | $125 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $122 |
| Viiv Healthcare Company | 1 | $121 |
| AbbVie | 5 | $118 |
| Pfizer | 5 | $104 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Stryker | 1 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $51 |
| Bayer | 2 | $45 |
| Boehringer Ingelheim | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Biogen | 2 | $41 |
| Eisai Inc. | 1 | $34 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Gilead | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,536 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $18,123 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $15,843 |
| JanuviaSitagliptin Phosphate | 12 | $12,066 |
| Atorvastatin Calcium | 239 | $3,713 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 78 | $2,150 |
| Amlodipine Besylate | 253 | $2,128 |
| Lidocaine | 18 | $1,995 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,818 |
| Nifedipine ErNifedipine | 46 | $1,194 |
| Lisinopril | 82 | $807 |
| Rosuvastatin Calcium | 23 | $769 |
| Losartan Potassium | 64 | $759 |
| Duloxetine Hcl | 27 | $693 |
| Metoprolol Succinate | 52 | $681 |
| Metformin Hcl | 82 | $649 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $104 | $18,12326 claims |
| GSKTrelegy Ellipta | $444 | $15,84321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Other nurse practitioner in Baltimore
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Zeev NemirovskyBaltimore$19K
- Stephanie HorrocksBaltimore$12K
- Sandra WoodringBaltimore$12K
- Inna BardoffBaltimore$11K
- Linda RyanBaltimore$10K
- Laura HostovichBaltimore$8K
- Denese GaughanBaltimore$7K
- Arita McCoyBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.